Search - tctmd.com

Displaying 41 - 60 of 2485

Sort: Relevancy | Date

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

News Conference News AHA 2025

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

November 08, 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

What’s Going to Be Hot at AHA 2025?

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

November 04, 2025

What Makes MedTech Great—or Not—and Envisioning Its Future

News Conference News TCT 2025

What Makes MedTech Great—or Not—and Envisioning Its Future

November 04, 2025

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

News Conference News TCT 2025

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

October 31, 2025

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

News Conference News TCT 2025

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

October 28, 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

October 27, 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

October 27, 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

TCT 1086: The Effect of Marijuana Use on Outcomes Following PCI in an Urban Tertiary Care Center, An Updated Analysis

Presenter: Vaishnavi Sirekulam

October 27, 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

News Conference News TCT 2025

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

October 26, 2025

Presentation TCT 2025

TCT 1073: Impact of a Care Coordination Platform on Reperfusion Times for STEMI Patients in a Regional Hub-and-Spoke System

Presenter: Marco Spaziano

October 26, 2025

Concerto in the Cath Lab: Music Benefits Heart Health After PCI

News Conference News TCT 2025

Concerto in the Cath Lab: Music Benefits Heart Health After PCI

Michael O'Riordan

October 25, 2025

Prenatal Hyperlipidemia: ‘Canary in a Coal Mine’ for Maternal Health?

News Daily News

Prenatal Hyperlipidemia: ‘Canary in a Coal Mine’ for Maternal Health?

October 17, 2025

Mortality at 4 Years After TAVI Explant Linked to Hospital Volume: Medicare Data

News Conference News EACTS 2025

Mortality at 4 Years After TAVI Explant Linked to Hospital Volume: Medicare Data

Yael L. Maxwell

October 16, 2025

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

News Daily News

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

October 16, 2025

Getting Ready for a Heart Failure Polypill, Well Before the Data Are In

News Daily News

Getting Ready for a Heart Failure Polypill, Well Before the Data Are In

October 16, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.